Stamos Capital Partners, L.P. Iqvia Holdings Inc. Transaction History

Stamos Capital Partners, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$183.66 - $224.77 $1.9 Million - $2.33 Million	10,360 New	10,360 $2.33 Million
Q3 2022 Nov 10, 2022	BUY	$181.14 - $248.26 $115,929 - $158,886	640 Added 31.37%	2,680 $485,000
Q1 2022 May 13, 2022	BUY	$210.56 - $273.58 $429,542 - $558,103	2,040 New	2,040 $472,000
Q4 2019 Feb 14, 2020	SELL	$137.59 - $155.95 $143,643 - $162,811	-1,044 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$148.25 - $161.46 $171,377 - $186,647	-1,156 Reduced 52.55%	1,044 $156,000
Q2 2019 Aug 14, 2019	SELL	$132.28 - $160.9 $145,508 - $176,990	-1,100 Reduced 33.33%	2,200 $354,000
Q1 2019 May 10, 2019	SELL	$109.96 - $144.45 $406,852 - $534,465	-3,700 Reduced 52.86%	3,300 $473,000
Q4 2018 Feb 14, 2019	BUY	$105.7 - $130.35 $739,900 - $912,450	7,000 New	7,000 $813,000

1,137

142M

828K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $35.8B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Stamos Capital Partners, L.P. with notifications on news.